$Hyphens Pharma(1J5.SG$ showed solid growth the last few quarters after their last acquisition, with 4% dividend and potential for more growth with their digital arm, albeit a bit slow.
$APAC Realty(CLN.SG$
considerably cheaper than Propnex. still have room to run
considerably cheaper than Propnex. still have room to run
3
2